Novel triazole antifungal agents

Expert Opinion on Investigational Drugs

Volumn 9, Issue 3, 2000, Pages 593-605

  Hoffman, H L ^a   Ernst, E J ^a   Klepser, M E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antifungal; Posaconazole (SCH 56592); Ravuconazole (BMS 207,147); Triazole; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ASPERGILLUS; BLASTOMYCES DERMATITIDIS; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL TRIAL; COCCIDIOIDES IMMITIS; DRUG BIOAVAILABILITY; HISTOPLASMA CAPSULATUM; HUMAN; META ANALYSIS; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; REVIEW;

EID: 0034001737     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.3.593     Document Type: Review

References (64)